Evidence map›Paper›PMID 35041803›Full record

ArticleCell systems2022

Direct analysis of ribosome targeting illuminates thousand-fold regulation of translation initiation.

Rachel O Niederer, Maria F Rojas-Duran, Boris Zinshteyn, Wendy V Gilbert

Open access · greenAbstract read
In one paragraph

Article in Cell systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Uncovering mRNA sequences that control translation initiation.Nature reviews. Molecular cell biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Current Non-Viral-Based Strategies to Manufacture CAR-T Cells.International journal of molecular sciences · 2024
    Review
  20. A statistical-physics approach for codon usage optimisation.Computational and structural biotechnology journal · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rachel O NiedererDepartment of Molecular Biophysics & Biochemistry, Yale School of Medicine, New Haven, CT 06520, USA.
Maria F Rojas-DuranDepartment of Molecular Biophysics & Biochemistry, Yale School of Medicine, New Haven, CT 06520, USA.
Boris ZinshteynDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Wendy V GilbertDepartment of Molecular Biophysics & Biochemistry, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: wendy.gilbert@yale.edu.
Yale University · USMassachusetts Institute of Technology · US

Funding

Translational Control by 5'-untranslated regionsR01GM132358 · NIGMS · YALE UNIVERSITY · PI GILBERT, WENDY VICTORIA · 2019 to 2022
$1.4M
Translational control by 5'-UTR elementsK99GM135533 · NIGMS · YALE UNIVERSITY · PI NIEDERER, RACHEL O. · 2020 to 2021
$188k
NIGMS NIH HHS K99 GM135533NIGMS NIH HHS R01 GM132358
6 · The paper itself

Abstract

Translational control shapes the proteome in normal and pathophysiological conditions. Current high-throughput approaches reveal large differences in mRNA-specific translation activity but cannot identify the causative mRNA features. We developed direct analysis of ribosome targeting (DART) and used it to dissect regulatory elements within 5' untranslated regions that confer 1,000-fold differences in ribosome recruitment in biochemically accessible cell lysates. Using DART, we determined a functional role for most alternative 5' UTR isoforms expressed in yeast, revealed a general mode of increased translation via direct binding to a core translation factor, and identified numerous translational control elements including C-rich silencers that are sufficient to repress translation both in vitro and in vivo. DART enables systematic assessment of the translational regulatory potential of 5' UTR variants, whether native or disease-associated, and will facilitate engineering of mRNAs for optimized protein production in various systems.

Indexed as

Protein BiosynthesisRibosomes5' Untranslated RegionsRegulatory Sequences, Nucleic AcidRNA, MessengerSaccharomyces cerevisiae5' Untranslated RegionsRNA, Messenger5′-UTRribosome recruitmenttranslational controltranslation initiation

Identifiers

PMID35041803
PMCPMC8930539
OpenAlexW4220999243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.